WallStreetZenWallStreetZen

NYSEMKT: ARMP
Armata Pharmaceuticals Inc Stock Ownership - Who owns Armata Pharmaceuticals?

Insider buying vs selling

Have Armata Pharmaceuticals Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when ARMP insiders and whales buy or sell their stock.

ARMP Shareholders

What type of owners hold Armata Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Innoviva Inc69.37%25,076,769$101.31MInsider
Randal J. Kirk61.33%22,169,127$89.56MInsider
Biogen Inc38.56%13,939,158$56.31MInsider
Elan Corp PLC32.16%11,626,282$46.97MInsider
Austin W. Greenhouse David M. Marxe6.52%2,355,475$9.52MInsider
Delta Dental Of Wisconsin Inc5.83%2,107,675$8.52MInsider
Louis P. Lacasse4.01%1,450,185$5.86MInsider
Delta Dental Plan Of Michigan Inc3.50%1,265,802$5.11MInsider
Bank Of America Corp1.76%634,451$2.56MInstitution
Jeremy Curnock Cook1.14%411,435$1.66MInsider

1 of 3

ARMP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ARMP1.55%98.45%
NVCT8.52%50.88%Net BuyingNet Buying
CTMX48.20%30.73%Net SellingNet Selling
CLLS17.66%0.00%
DBVT39.10%15.37%Net BuyingNet Buying

Armata Pharmaceuticals Stock Ownership FAQ

Who owns Armata Pharmaceuticals?

Armata Pharmaceuticals (NYSEMKT: ARMP) is owned by 3.57% institutional shareholders, 227.09% Armata Pharmaceuticals insiders, and 0.00% retail investors. Innoviva Inc is the largest individual Armata Pharmaceuticals shareholder, owning 25.08M shares representing 69.37% of the company. Innoviva Inc's Armata Pharmaceuticals shares are currently valued at $102.81M.

If you're new to stock investing, here's how to buy Armata Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.